Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Etiology of Ibrutinib Therapy Discontinuation and Outcome... | ResearchHub
Paper
Paper
Search...
Search ResearchHub...
Ctrl+K
New
Home
Browse
Earn
Fund
RH Journal
Notebook
Lists
Leaderboard
RSC
USD
Changelog
Terms
Privacy
Issues
Docs
Support
Foundation
About
Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia
0
Authors
Kami Maddocks
22 more
Kami Maddocks
•
Amy Ruppert
20 more
•
Jennifer Woyach
Published
February 26, 2015
Paper
Conversation
0
Reviews
0
Bounties
0
Sign in to comment
Add a comment...
Best
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
JAMA Oncology
Topics
Medicine
Cancer Oncology
Immunology
Internal Medicine
Genetics
Show all topics
DOI
10.1001/jamaoncol.2014.218
Other Formats
PDF
Supporters
Support the authors with ResearchCoin
Tip RSC
Journal
JAMA Oncology
Topics
Medicine
Cancer Oncology
Immunology
Internal Medicine
Genetics
Show all topics
DOI
10.1001/jamaoncol.2014.218
Other Formats
PDF
